News

All About Tariffs: Five Questions for the ECB
Most likely. Traders fully price a 25-basis-point cut, bringing the ECB's deposit rate to 2.25% next Thursday, a move they ...
Microsoft surveys users about new icon designs in Word, Excel, and PowerPoint
The discovery was first reported by Windows Central, which received details about the survey from a reader who shared the ...
ChargePoint price target lowered to 50c from 75c at Goldman Sachs
Goldman Sachs lowered the firm’s price target on ChargePoint (CHPT) to 50c from 75c and keeps a Sell rating on the shares. The firm reduced its ...
These might be Microsoft’s new Office icons
Microsoft hasn’t redesigned its Office app icons since 2018, when it launched a modern look for apps like Word, Excel, ...
Microsoft offers a gift card to a select few for feedback on new Office icons
Microsoft wants user feedback on redesigned app icons for its Office suite, including Word and Excel. What do you think of ...
US Tariffs, China Slowdown Cloud Developing Asia's Growth Outlook, Says ADB
In its Asian Development Outlook report, the ADB projected that growth in developing Asia will ease slightly to 4.9% in 2025 ...
Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 ISELIN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc.